PatientPoint brings collectively two companies in pursuit of 1 mission—making each doctor-patient engagement higher®. The mixed firm will assist meet the tech-enabled affected person engagement wants of practically 150,000 distinctive healthcare suppliers and affect roughly 750 million affected person visits annually.
“This well timed, strategic transaction each underscores our dedication to development, and to providing our high-value, tech-enabled affected person engagement options to as many suppliers as potential to assist them meet the calls for of a quickly evolving healthcare business,” stated PatientPoint Founder and CEO Mike Collette. “By leveraging the perfect expertise and expertise from each PatientPoint and Consequence Well being, we will probably be nicely positioned to broaden our suite of modern affected person engagement options to ship improved affected person outcomes and a extra personalised, related affected person expertise in addition to enhanced scale and effectivity for our healthcare sponsors.”
PatientPoint Well being Applied sciences will probably be led by PatientPoint’s present management crew together with Mike Collette as CEO, Linda Ruschau as Chief Consumer Officer, Pat O’Brien as Chief Monetary Officer and Chris Martini as Chief Supplier Officer. PatientPoint’s engineering and data expertise groups will even be augmented by Consequence Well being tech executives Glenn Keighley and Sean Barden.
“Now we have nice respect for the substantial supplier community the Consequence Well being crew has constructed in addition to the compelling options they’ve developed to counterpoint the affected person’s point-of-care expertise,” Collette stated. “We additionally commend CEO Matt McNally and COO Nandini Ramani for main Consequence Well being’s unbelievable turnaround and rebuilding consumer belief.”
The brand new platform firm plans to leverage a mix of natural development and M&A to proceed to develop its supplier base and to broaden the suite of modern, tech-enabled affected person engagement options it may supply to its supplier clients.
“Each key healthcare stakeholder wins with our distinctive enterprise mannequin: Sufferers obtain improved well being outcomes and an enhanced affected person expertise, healthcare suppliers obtain modern, high-value affected person engagement options for free of charge or low price, and healthcare sponsors that financially assist our applications obtain forecast-altering gross sales development at a compelling ROI,” Collette stated.
The mixed entity will probably be majority owned by a gaggle of traders together with funds managed by L Catterton and Littlejohn & Co., LLC.
PatientPoint ® is the trusted associate for tech-enabled affected person engagement options that improve the affected person expertise throughout your complete care journey. Our options create more practical doctor-patient interactions and ship excessive worth for sufferers, suppliers and healthcare sponsors. By our 150k distinctive healthcare supplier relationships, PatientPoint’s options affect roughly 750 million affected person visits annually, additional advancing our mission of creating each doctor-patient engagement higher®. Study extra at patientpoint.com.